Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Cited In for PubMed (Select 16682640)

1.

Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.

Tabariès S, Ouellet V, Hsu BE, Annis MG, Rose AA, Meunier L, Carmona E, Tam CE, Mes-Masson AM, Siegel PM.

Breast Cancer Res. 2015 Mar 27;17:45. doi: 10.1186/s13058-015-0558-3.

2.

Human polymorphonuclear neutrophils specifically recognize and kill cancerous cells.

Yan J, Kloecker G, Fleming C, Bousamra M 2nd, Hansen R, Hu X, Ding C, Cai Y, Xiang D, Donninger H, Eaton JW, Clark GJ.

Oncoimmunology. 2014 Jul 3;3(7):e950163. eCollection 2014.

PMID:
25610737
4.

The use of anchored agonists of phagocytic receptors for cancer immunotherapy: B16-F10 murine melanoma model.

Janotová T, Jalovecká M, Auerová M, Švecová I, Bruzlová P, Maierová V, Kumžáková Z, Cunátová Š, Vlčková Z, Caisová V, Rozsypalová P, Lukáčová K, Vácová N, Wachtlová M, Salát J, Lieskovská J, Kopecký J, Ženka J.

PLoS One. 2014 Jan 13;9(1):e85222. doi: 10.1371/journal.pone.0085222. eCollection 2014.

5.

Membrane permeability of the human granulocyte to water, dimethyl sulfoxide, glycerol, propylene glycol and ethylene glycol.

Vian AM, Higgins AZ.

Cryobiology. 2014 Feb;68(1):35-42. doi: 10.1016/j.cryobiol.2013.11.004. Epub 2013 Nov 20.

6.

Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma model.

Qu X, Felder MA, Perez Horta Z, Sondel PM, Rakhmilevich AL.

Int Immunopharmacol. 2013 Dec;17(4):1141-7. doi: 10.1016/j.intimp.2013.10.019. Epub 2013 Nov 4.

7.

Toward a universal treatment for cancer: cell inflation assisted chemotherapy.

Corcos D.

Cancer Med. 2013 Aug;2(4):421-6. doi: 10.1002/cam4.91. Epub 2013 May 28. Review.

8.

Vaccinia virus-mediated expression of human erythropoietin in tumors enhances virotherapy and alleviates cancer-related anemia in mice.

Nguyen DH, Chen NG, Zhang Q, Le HT, Aguilar RJ, Yu YA, Cappello J, Szalay AA.

Mol Ther. 2013 Nov;21(11):2054-62. doi: 10.1038/mt.2013.149. Epub 2013 Jun 14.

9.

Autologous immune enhancement therapy: A case report of a stage IV colonic cancer.

Subramani B, Ratnavelu K, Pullai CR, Krishnan K, Sugadan SD, Deng X, Hiroshi T.

Oncol Lett. 2013 May;5(5):1611-1614. Epub 2013 Mar 12.

10.

Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.

Liu Z, Zhao X, Mao H, Baxter PA, Huang Y, Yu L, Wadhwa L, Su JM, Adesina A, Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, Hurwitz RL, Lau CC, Chintagumpala M, Blaney SM, Li XN.

Neuro Oncol. 2013 Sep;15(9):1173-85. doi: 10.1093/neuonc/not065. Epub 2013 May 7.

11.

Immune cells from SR/CR mice induce the regression of established tumors in BALB/c and C57BL/6 mice.

Koch J, Hau J, Pravsgaard Christensen J, Elvang Jensen H, Bagge Hansen M, Rieneck K.

PLoS One. 2013;8(3):e59995. doi: 10.1371/journal.pone.0059995. Epub 2013 Mar 21.

12.

Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Jaganjac M, Poljak-Blazi M, Schaur RJ, Zarkovic K, Borovic S, Cipak A, Cindric M, Uchida K, Waeg G, Zarkovic N.

Clin Exp Immunol. 2012 Nov;170(2):178-85. doi: 10.1111/j.1365-2249.2012.04639.x.

13.

Opposing roles for complement component C5a in tumor progression and the tumor microenvironment.

Gunn L, Ding C, Liu M, Ma Y, Qi C, Cai Y, Hu X, Aggarwal D, Zhang HG, Yan J.

J Immunol. 2012 Sep 15;189(6):2985-94. doi: 10.4049/jimmunol.1200846. Epub 2012 Aug 22.

14.

T-cell-independent antitumor effects of CD40 ligation.

Rakhmilevich AL, Alderson KL, Sondel PM.

Int Rev Immunol. 2012 Aug;31(4):267-78. doi: 10.3109/08830185.2012.698337. Review.

15.

Study on the immunomodulation effect of Isodon japonicus extract via splenocyte function and NK anti-tumor activity.

Hwang YJ, Kim J, Park DS, Hwang KA.

Int J Mol Sci. 2012;13(4):4880-8. doi: 10.3390/ijms13044880. Epub 2012 Apr 18.

16.

Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.

Liu Y, Zeng G.

J Immunother. 2012 May;35(4):299-308. doi: 10.1097/CJI.0b013e3182518e83. Review.

17.

A survey on the distribution of healthy people with different anti-tumour ability.

Gao Y, Xu X, Dong Z, Jiang C, Gao J, Hu J, Gui J, Wang H, Tian Y.

Arch Med Sci. 2010 Oct;6(5):806-14. doi: 10.5114/aoms.2010.17099. Epub 2010 Oct 26.

18.

Tumor entrained neutrophils inhibit seeding in the premetastatic lung.

Granot Z, Henke E, Comen EA, King TA, Norton L, Benezra R.

Cancer Cell. 2011 Sep 13;20(3):300-14. doi: 10.1016/j.ccr.2011.08.012.

19.

Novel innate cancer killing activity in humans.

Blanks MJ, Stehle JR Jr, Du W, Adams JM, Willingham MC, Allen GO, Hu JJ, Lovato J, Molnar I, Cui Z.

Cancer Cell Int. 2011 Aug 3;11:26. doi: 10.1186/1475-2867-11-26.

20.

Activation of cytotoxic and regulatory functions of NK cells by Sindbis viral vectors.

Granot T, Venticinque L, Tseng JC, Meruelo D.

PLoS One. 2011;6(6):e20598. doi: 10.1371/journal.pone.0020598. Epub 2011 Jun 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk